Profacgen Provides a Comprehensive Portfolio of Protein Expression Systems for Protein Research

 Breaking News
  • No posts were found

Profacgen Provides a Comprehensive Portfolio of Protein Expression Systems for Protein Research

Profacgen now provides a comprehensive portfolio of protein expression systems to perform thorough feasibility analysis before the initiation of each protein expression project.

New York, USA – April 29, 2021 – With years of experience in providing contract research services, Profacgen now provides a comprehensive portfolio of protein expression systems to perform thorough feasibility analysis before the initiation of each protein expression project.

Recombinant protein expression is a technique that uses recombinant DNA technology to produce a protein of interest. Now, it is commonly used in biological research and in the pharmaceutical production of recombinant protein therapeutics. Recombinant DNA (usually the cDNA sequence of the target protein) is designed to be under the control of a well-characterized promoter and to express the target protein within selected host cells to achieve high levels of protein expression.

The selection of an appropriate protein expression system is the key to the successful expression of recombinant proteins. Several factors need to be considered, including the characteristics of the target protein, the intended application, the yield and cost of the protein. In addition, there are challenges for many protein expression projects, especially large proteins, membrane proteins, nuclear proteins and proteins with a large number of post-translational modifications.

With customized technical strategies, flexible production scale, and proprietary technologies, Profacgen now offers Corynebacterium glutamicum Expression Systems, Animal-Free Expression, Bacteria Expression, Baculovirus-Mammalian cell Protein Expression System, Cell-Free Protein Expression, Fusion Protein Expression, Insect Cell Expression, Mammalian Cell Expression, Membrane Protein Expression and Purification, NovEgg Expression System, Protein co-expression, Recombinant Membrane Protein Production, Trimeric Protein Production Service, Yeast Expression, and Antibiotic-free Expression System.

“We provide customers with efficient and high-quality recombinant protein production, process development and large-scale production for downstream applications, such as functional assays, structural studies, target validation and high-throughput screening,” commented Crystal, the chief marketing staff at Profacgen.

“With the advanced in-house platform, we confidently provide small to large-scale production and purification services for your choice of protein,” added Crystal.

To view the whole list of protein expression systems offered by Profacgen, you can visit https://www.profacgen.com/protein-expression.htm.

About Profacgen

Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development.

Media Contact
Company Name: Profacgen
Contact Person: Ellen
Email: Send Email
Phone: 1-516-855-7709
Country: United States
Website: https://www.profacgen.com

Categories